Soleno Therapeutics Appoints Mark W. Hahn to Board and Audit Committee
Less than 1 min read
On October 13, 2025, Soleno Therapeutics, Inc. announced the appointment of Mark W. Hahn to its Board of Directors and Audit Committee. Mr. Hahn will serve as a Class II director with a term expiring at the 2028 annual meeting of stockholders.
| Individual | Mark W. Hahn |
| Role | Board Member, Audit Committee Member |
| Type of Change | Appointed |
| Effective Date | October 13, 2025 |
| Reason | Not disclosed |
| Replacement Info | N/A |
| Background Details | Nearly 30 years of CFO-level experience, key roles in product launches and strategic transactions |
| Board/Committee Role Changes | Not disclosed |
Original SEC Filing: SOLENO THERAPEUTICS INC [ SLNO ] - 8-K - Oct. 14, 2025
AI-powered summaries may contain inaccuracies. Consider verifying important information with the source.